Drugs News and Research

RSS

Study identifies specific coping behaviors through which stress exposure leads to insomnia

A new study is the first to identify specific coping behaviors through which stress exposure leads to the development of insomnia.

4 Jul 2014

Beleodaq gets FDA approval for treatment of patients with peripheral T-cell lymphoma

The U.S. Food and Drug Administration today approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of non-Hodgkin lymphoma (NHL). The action was taken under the agency's accelerated approval program.

3 Jul 2014

BINDER ultra low temperature freezer provides high safety for biological samples

In the field of cell biology in particular, a wide variety of samples including nucleic acid or protein samples have to be preserved for longer periods of time. At temperatures down to – 86°C, samples often remain frozen for several weeks up to several years. 100% reliability of the cooling system is essential. Otherwise, any interruption could result in the complete loss of the research results, requiring the results to be recreated, which costs time and money.

From BINDER GmbH 3 Jul 2014

New research examines brain effects of the psychedelic chemical in magic mushrooms

New research shows that our brain displays a similar pattern of activity during dreams as it does during a mind-expanding drug trip.

3 Jul 2014

WHO presents new framework to eliminate TB in 33 countries

The World Health Organization today, together with the European Respiratory Society, presented a new framework to eliminate tuberculosis (TB) in countries with low levels of the disease. Today there are 33 countries and territories where there are fewer than 100 TB cases per million population.

3 Jul 2014

FDA grants Fast Track designation to Akashi Therapeutics' HT-100 for treatment of DMD

Akashi Therapeutics, Inc., announced today that the U.S. Food and Drug Administration has granted Fast Track designation to the company's most advanced product candidate, HT-100 (delayed-release halofuginone), an orally available, small molecule drug candidate intended to reduce fibrosis and inflammation and promote healthy muscle regeneration in boys with DMD.

3 Jul 2014

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.

3 Jul 2014

Analysis of clinical trials reveals urgent need to increase Alzheimer's drug development

Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer's disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments.

3 Jul 2014

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

3 Jul 2014

New meta-analysis highlights significant gaps in hepatitis C care

A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs.

3 Jul 2014

Galderma's trifarotene molecule gets FDA Orphan Drug Designation for treatment of congenital ichthyosis

Galderma announces that the U.S. FDA granted Orphan Drug Designation status for the company's trifarotene molecule for the treatment of congenital ichthyosis. Based on this decision, Galderma plans to implement a clinical development plan, reinforcing its commitment to exploring new treatment options for rare diseases, as well as meeting the needs of all patients with skin diseases over the course of their lives.

2 Jul 2014

Prescription drug deaths drop in Fla. after crackdown on doctors

Deaths involving narcotic painkillers dropped 26 percent over two years in Florida after stricter doctor scrutiny, according to a report from the federal Centers for Disease Control and Prevention.

2 Jul 2014

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Isis Pharmaceuticals, Inc. announced today that it has earned a $1 million payment from GlaxoSmithKline related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV).

2 Jul 2014

Surgical treatment improves survival for metastatic melanoma patients whose disease is limited to the liver

Surgical resection markedly improves survival among metastatic melanoma patients whose disease is isolated to a few areas in the liver, according to new study findings published in the July issue of the Journal of the American College of Surgeons.

2 Jul 2014

USA witnesses dramatic slowdown in health spending growth over last decade

Growth in health expenditure in the USA slowed dramatically between 2000 and 2011, bringing the growth rate of the country’s health budget in line with other high-spending countries, according to new research published in The Lancet as part of a new Series, The health of Americans.

2 Jul 2014

CHOP study: Children with specific gene variants may require higher doses of pain-control drugs

In the first genome-wide analysis of postsurgical pain in children, pediatric researchers identified variations in genes that affect a child's need for pain-control drugs. The findings suggest that at some point physicians may calibrate pain-medication dosages according to a child's individual genetic makeup.

2 Jul 2014

Mayo Clinic researchers uncover 31 genes key to clear cell renal cell carcinoma

A genomic analysis of clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, from 72 patients has uncovered 31 genes that are key to development, growth and spread of the cancer, say researchers from Mayo Clinic in Florida.

2 Jul 2014

New compound blocks action of key 'gatekeeper' enzyme for malaria parasite survival

Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival.

2 Jul 2014

Viewpoints: Hobby Lobby decision celebrated and panned; gender and religious politics explored

In ruling 5 to 4 that "closely held" companies can refuse on religious grounds to include contraceptives in their employees' health plans, the Supreme Court has needlessly interfered with an important provision of the Affordable Care Act. And it has done more than that (7/1).

1 Jul 2014

Study details brain mechanisms involved with addictive substances

The National Institutes of Health has turned to neuroscientists at the nation's most "Stone Cold Sober" university for help finding ways to treat drug and alcohol addiction.

1 Jul 2014

Drugs News and Research

Study identifies specific coping behaviors through which stress exposure leads to insomnia

Beleodaq gets FDA approval for treatment of patients with peripheral T-cell lymphoma

BINDER ultra low temperature freezer provides high safety for biological samples

New research examines brain effects of the psychedelic chemical in magic mushrooms

WHO presents new framework to eliminate TB in 33 countries

FDA grants Fast Track designation to Akashi Therapeutics' HT-100 for treatment of DMD

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Analysis of clinical trials reveals urgent need to increase Alzheimer's drug development

Researchers identify genetic mutation that may cause parkinsonism in young people

New meta-analysis highlights significant gaps in hepatitis C care

Galderma's trifarotene molecule gets FDA Orphan Drug Designation for treatment of congenital ichthyosis

Prescription drug deaths drop in Fla. after crackdown on doctors

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Surgical treatment improves survival for metastatic melanoma patients whose disease is limited to the liver

USA witnesses dramatic slowdown in health spending growth over last decade

CHOP study: Children with specific gene variants may require higher doses of pain-control drugs

Mayo Clinic researchers uncover 31 genes key to clear cell renal cell carcinoma

New compound blocks action of key 'gatekeeper' enzyme for malaria parasite survival

Viewpoints: Hobby Lobby decision celebrated and panned; gender and religious politics explored

Study details brain mechanisms involved with addictive substances

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News